What is STERIS?
STERIS is a infection prevention and sterilization services company serving enterprise, commercial, consumer, healthcare, financial, real estate, or regulated-market customers.
- Category
- Infection prevention and sterilization services
- Headquarters
- Dublin, Ireland
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; NYSE: STE
What is STERIS?
STERIS is a infection prevention and sterilization services company headquartered in Dublin, Ireland. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
STERIS is a infection prevention and sterilization services company headquartered in Dublin, Ireland. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, STERIS should be mapped as a scaled public-company account. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does STERIS offer?
STERIS's profile centers on Sterilization services, Infection prevention, Surgical equipment, Life sciences services.
- Sterilization services· Infection prevention and sterilization services
- Infection prevention· Infection prevention and sterilization services
- Surgical equipment· Infection prevention and sterilization services
- Life sciences services· Infection prevention and sterilization services
- Healthcare products· Infection prevention and sterilization services
- Decontamination· Infection prevention and sterilization services
How does STERIS make money?
STERIS makes money through commercial activity tied to infection prevention and sterilization services.
STERIS monetizes through the model common to infection prevention and sterilization services: product sales, recurring services, contracts, leases, subscriptions, transaction volume, servicing, investment management, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, occupancy, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads STERIS?
STERIS's named executives should be verified on the official leadership or investor-relations page before outreach.
- STERIS executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- STERIS finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- STERIS operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact STERIS's leadership?
STERIS should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.steris.comHow is STERIS funded?
STERIS's current status is Public company; NYSE: STE.
STERIS's capital profile is best understood through its current public-company status: Public company; NYSE: STE. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capital expenditure plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did STERIS get here?
STERIS's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingSTERIS is foundedThe company begins building in infection prevention and sterilization services.
- Scale-upCommercial footprint expandsSTERIS broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; NYSE: STEPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are STERIS's competitors?
STERIS competes with larger incumbents and focused specialists in infection prevention and sterilization services.
STERIS — frequently asked questions
